These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 11414163

  • 1. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Lems WF, van de Laar MA, Bijlsma JW.
    Ned Tijdschr Geneeskd; 2001 Jun 02; 145(22):1044-7. PubMed ID: 11414163
    [Abstract] [Full Text] [Related]

  • 2. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 02; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov 02; 38(11):81-6. PubMed ID: 11138599
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct 02; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [Abstract] [Full Text] [Related]

  • 7. [A critical evaluation of side effect data on COX-2 inhibitors].
    Pomp E.
    Tidsskr Nor Laegeforen; 2002 Feb 20; 122(5):476-80. PubMed ID: 11961974
    [Abstract] [Full Text] [Related]

  • 8. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov 20; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
    Umar A, Boisseau M, Yusup A, Upur H, Bégaud B, Moore N.
    Fundam Clin Pharmacol; 2004 Oct 20; 18(5):559-63. PubMed ID: 15482377
    [Abstract] [Full Text] [Related]

  • 11. Are selective COX 2 inhibitors superior to traditional NSAIDs? Both the CLASS and VIGOR trials support the COX 2 hypothesis.
    Stover RR.
    BMJ; 2002 Jul 20; 325(7356):161; author reply 161. PubMed ID: 12134855
    [No Abstract] [Full Text] [Related]

  • 12. [Gastrointestinal damage induced by celecoxib and rofecoxib in rats].
    Laudanno OM, Cesolari JA, Esnarriaga J, Rista L, Piombo G, Maglione C, Aramberry LJ, Sambrano JS, Godoy A, Rocaspana A.
    Acta Gastroenterol Latinoam; 2000 Jul 20; 30(1):27-33. PubMed ID: 10855352
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
    Chaabouni H, Amouri A, Cheikh I, Kchaou M, Ouerghi H, Ben Mami N, Ben Ammar A.
    Tunis Med; 2002 Aug 20; 80(8):427-33. PubMed ID: 12703120
    [Abstract] [Full Text] [Related]

  • 15. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A, Krahn M, Naglie G.
    Arthritis Rheum; 2003 Jun 15; 49(3):283-92. PubMed ID: 12794781
    [Abstract] [Full Text] [Related]

  • 16. [Specific cyclo-oxygenase inhibitors. 2. Gastric toxicity?].
    Blondon H.
    Presse Med; 2000 Mar 11; 29(9):482-3. PubMed ID: 10745938
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct 11; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [Abstract] [Full Text] [Related]

  • 18. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E, Bardou M, Dasgupta K, Toubouti Y, Ghosn J, Barkun AN.
    Rheumatology (Oxford); 2007 Feb 11; 46(2):265-72. PubMed ID: 16844699
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase (COX-2) selective inhibitors. Any better than NSAIDs?
    Nguyen A, Chaiton A.
    Can Fam Physician; 2001 Jul 11; 47():1398-400. PubMed ID: 11494927
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.